U.S. Patent Reform Effort Narrowed in Congress; Could Resurface In Supreme Court
By Sarah Lai Stirland for Intellectual Property Watch A wall of opposition from the biotechnology, pharmaceutical and independent inventor communities this year gutted some of the most controversial provisions from an ambitious patent reform bill introduced in July in the…
